The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Generative Artificial Intelligence (AI) In Drug Discovery Market Expected To Change Between 2026 And 2030?

The generative artificial intelligence (AI) in drug discovery market size has experienced significant expansion in recent years. This market is expected to expand from $0.25 billion in 2025 to $0.33 billion in 2026, achieving a compound annual growth rate (CAGR) of 30.6%. The historical growth of this market can be attributed to several factors such as high drug development costs, the growth in computational chemistry, the availability of biological datasets, the adoption of machine learning tools, and pharmaceutical r&d investment.

The market for generative artificial intelligence (AI) in drug discovery is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $0.86 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 27.0%. Key drivers for this growth during the forecast period include the incorporation of generative models into research pipelines, the increasing need for expedited drug discovery processes, the broadening scope of biologics optimization, strategic alliances between AI companies and pharmaceutical firms, and a decrease in the time required to bring products to market. Significant trends identified for the projection period encompass the escalating embrace of AI for molecule generation, a heightened application of deep learning techniques in drug design, the broadened utility of small molecule discovery, the increasing integration of AI in lead optimization, and the expedited development of drugs in their initial stages.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16067&type=smp

What Underlying Factors Are Accelerating The Growth Of The Generative Artificial Intelligence (AI) In Drug Discovery Market?

The increasing volume of clinical trials is anticipated to fuel the expansion of generative AI within the drug discovery market. These trials, involving human participants, evaluate the safety and efficacy of novel medical treatments or procedures, with the goal of collecting scientific data to confirm their appropriateness for human application. This growth in clinical trials stems mainly from progress in medical research, a higher incidence of diseases, evolving regulatory frameworks, the global expansion of clinical studies, greater patient advocacy and awareness, competitive industry pressures, technological innovations, and available funding. Data from clinical trials serves as input for generative AI models, accelerating drug discovery processes by enabling the prediction of interactions and the design of new compounds. This collaborative approach facilitates personalized medical treatments, enhances the effectiveness of therapies, leads to better patient results, and transforms the pharmaceutical sector. For example, data from Pharmaceutical Technology, a UK-based business news and media firm, indicates that 3,213 trials are scheduled to commence in January 2025, with 823 in Phase I and 1,102 in Phase II. Similar to 2024, oncology is projected to maintain its position as the leading therapeutic field, comprising 946 trials. The central nervous system follows with 686 trials, and cardiovascular trials are further behind with 258. Consequently, the increased volume of clinical trials is a key factor propelling the expansion of generative AI in the drug discovery market.

How Is The Generative Artificial Intelligence (AI) In Drug Discovery Market Structured Across Different Segments?

The generative artificial intelligence (AI) in drug discovery market covered in this report is segmented –

1) By Type: Small Molecule, Large Molecule

2) By Technology: Deep Learning, Machine Learning, Reinforcement Learning, Molecular Docking, Quantum Computing

3) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutions, Contract Research Organizations (CROs), Other End-Users

Subsegments:

1) By Small Molecule: Drug Design And Optimization, Lead Discovery And Identification, Toxicology Prediction, Molecular Property Prediction, ADMET (Absorption, Distribution, Metabolism, Excretion, And Toxicity) Prediction

2) By Large Molecule: Protein Structure Prediction, Antibody Design, Biologics Optimization, Peptide Design, Biopharmaceutical Discovery And Optimization

What Key Developments And Trends Are Impacting The Generative Artificial Intelligence (AI) In Drug Discovery Market?

Leading companies in the generative AI in the drug discovery market are creating sophisticated AI-driven instruments to expedite drug discovery processes. These AI-powered tools quicken drug development by optimizing drug discovery, design, and clinical trial stages through predictive analytics and machine learning. They boost efficiency in areas such as target identification, compound screening (including virtual screening with AI), preclinical development, regulatory compliance, and manufacturing operations. For example, in May 2023, Google Cloud, a US-based cloud computing service from Google, launched two innovative AI-driven solutions. These solutions, the Target and Lead Identification Suite and the Multiomics Suite, are designed to enhance drug discovery and precision medicine across biotech, pharmaceutical, and public sector organizations. The Target and Lead Identification Suite aids researchers in understanding amino acid functions and predicting protein structures, while the Multiomics Suite speeds up the analysis and comprehension of genomic data, simplifying the development of personalized treatments.

Which Major Players Dominate The Generative Artificial Intelligence (AI) In Drug Discovery Market?

Major companies operating in the generative artificial intelligence (AI) in drug discovery market are Bayer AG, NVIDIA Corporation, Merck KGaA, IBM Research, Schrödinger Inc., Valo Health, BenevolentAI, XtalPi Inc., Insilico Medicine Inc., Recursion Pharmaceuticals Inc., Exscientia, Atomwise Inc., InveniAI LLC, Healx, Aitia, Cloud Pharmaceuticals Inc., Optibrium, Aiforia, BioSymetrics Inc., Collaborations Pharmaceuticals Inc., MAbSilico, Reverie Labs, Standigm Inc., DeepMatter Group Limited, Variational AI Inc

Read the full generative artificial intelligence (ai) in drug discovery market report here:

https://www.thebusinessresearchcompany.com/report/generative-artificial-intelligence-ai-in-drug-discovery-global-market-report

Which Region Is Projected To Dominate The Generative Artificial Intelligence (AI) In Drug Discovery Market During The Forecast Period?

North America was the largest region in the generative AI in drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the generative artificial intelligence (AI) in drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Generative Artificial Intelligence (AI) In Drug Discovery Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16067&type=smp

Browse Through More Reports Similar to the Global Generative Artificial Intelligence (AI) In Drug Discovery Market 2026, By The Business Research Company

Generative Ai Global Market Report

https://www.thebusinessresearchcompany.com/report/generative-ai-global-market-report

Artificial Intelligence In Healthcare Market

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-market

Ai In Medical Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/ai-in-medical-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model